SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: As such, clinically used sodium-channel blockers are often considered proconvulsant in Dravet syndrome (52, 53), presumably because they inhibit the reduced Nav1.1 current even further.